Results 11 to 20 of about 7,038 (206)

Partial central diabetes insipidus during lithium use: A case report and literature review. [PDF]

open access: yesPCN Rep
Abstract Background Nephrogenic diabetes insipidus (NDI) is a well‐known adverse effect of lithium, which occurs in approximately 20%–40% of long‐term lithium users. Although rare, there have been reports of central diabetes insipidus (CDI) associated with lithium use.
Ichinose M   +9 more
europepmc   +3 more sources

Reversible Nephrogenic Diabetes Insipidus Induced by Lithium: A Case Report. [PDF]

open access: yesCase Rep Nephrol
Lithium is an effective mood stabilizer but may cause nephrogenic diabetes insipidus (NDI) by impairing the renal collecting duct response to arginine vasopressin (AVP). We report a 52‐year‐old woman on long‐term lithium therapy who presented with diarrhea, fatigue, polyuria, and confusion.
Uygun İlikhan S   +4 more
europepmc   +2 more sources

Desmopressin responding female nephrogenic diabetes insipidus: a case report [PDF]

open access: yesChildhood Kidney Diseases, 2022
Nephrogenic diabetes insipidus, decreased ability to concentrate urine, with production of large amounts of urine, is caused by the refractory response of renal tubules to the action of antidiuretic hormone.
Juyeon Lee   +3 more
doaj   +1 more source

Transient Postoperative Diabetes Insipidus With Hypovolemic Shock Temporally Associated With Dexmedetomidine, Propofol, and Sevoflurane: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Dexmedetomidine, propofol, and sevoflurane are widely used anesthetic agents, but reports of water metabolism disturbances—particularly drug‐induced diabetes insipidus (DI)—associated with their use remain extremely rare. We report a case of a 51‐year‐old Chinese man who developed abrupt high‐volume polyuria (> 600 mL/h; 24‐h output of 8750 mL)
Meng Y   +6 more
europepmc   +2 more sources

Hereditary tubulopathies accompanying polyuia

open access: yesRegulatory Mechanisms in Biosystems, 2021
Tubulopathies are a group of heterogeneous diseases that are manifested in the malfunction of the renal tubules. This review addresses tubulopathies associated with polyuria syndrome, namely renal glucosuria syndrome, nephrogenic diabetes insipidus and ...
M. O. Ryznychuk   +3 more
doaj   +1 more source

Lithium-induced nephrogenic diabetes insipidus following improved medication compliance: a case report. [PDF]

open access: yesJ Med Case Rep
Background Nephrogenic diabetes insipidus is a rare, often underrecognized complication of long-term lithium therapy. Lithium-induced nephrogenic diabetes insipidus results from chronic renal exposure, leading to significant polyuria, dehydration, and ...
Annor E   +3 more
europepmc   +2 more sources

Early onset of nephrogenic diabetes insipidus due to fabry disease in a child with GLA N215S mutation: Case report and literature review

open access: yesHeliyon, 2023
Background: Fabry disease (FD) is a rare X-linked lysosomal storage disorder. Renal involvement in FD is characterized by proteinuria and progressive renal decline.
Zhihong Lu   +5 more
doaj   +1 more source

Diabetes insipidus in mice with a mutation in aquaporin-2. [PDF]

open access: yesPLoS Genetics, 2005
Congenital nephrogenic diabetes insipidus (NDI) is a disease characterized by failure of the kidney to concentrate urine in response to vasopressin. Human kindreds with nephrogenic diabetes insipidus have been found to harbor mutations in the vasopressin
David J Lloyd   +3 more
doaj   +2 more sources

Perioperative Management of Lithium Therapy: Considerations and Recommendations. [PDF]

open access: yesBipolar Disord
Bipolar Disorders, Volume 28, Issue 1, February 2026.
Dominicus LS   +5 more
europepmc   +2 more sources

Type 1 Bartter syndrome presenting as primary diabetes insipidus: a rare Case Report with 8-year follow-up. [PDF]

open access: yesFront Genet
Type 1 Bartter syndrome (BS), a rare autosomal recessive salt-losing tubulopathy, classically presents with hyponatremia, hypochloremia, hypokalemic alkalosis, and hyperreninemic hyperaldosteronism. We report a male patient with the atypical presentation
Lu H, Liu S, Sun J, Mou L.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy